We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+33.36%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.6B
AUM Growth
+$6.01B
(+27%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-4.17%
Top 10 Holdings %
Top 10 Hldgs %
11.57%
Holding
713
New
83
Increased
216
Reduced
260
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$99.4M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$98.7M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$96.7M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$90.3M |
| 5 |
RTX Corp
RTX
|
+$82.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$122M |
| 2 |
Alibaba
BABA
|
+$107M |
| 3 |
Quest Diagnostics
DGX
|
+$107M |
| 4 |
Pfizer
PFE
|
+$88.9M |
| 5 |
Walt Disney
DIS
|
+$88.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.95% |
| 2 | Healthcare | 14.63% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
nLIGHT
LASR
$3.88B
| $6.69M | 0.02% |
+300,621
| New | +$5.69M |
|
477
Snap
SNAP
$7.89B
| $6.69M | 0.02% |
+284,635
| New | +$5.06M |
|
478
AdvanSix
ASIX
$541M
| $6.62M | 0.02% |
563,806
-23,800
| -4% | -$277K |
|
479
Host Hotels & Resorts
HST
$17.2B
| $6.59M | 0.02% |
+610,636
| New | +$7.01M |
|
|
NARI
480
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $6.5M | 0.02% |
+134,244
| New | +$6.41M |
|
481
Service Corp International
SCI
$11.7B
| $6.45M | 0.02% |
165,864
+22,648
| +16% | +$870K |
|
482
TSMC
TSM
$2.1T
| $6.43M | 0.02% |
113,291
-29,106
| -20% | -$1.53M |
|
|
CNP.PRB
483
DELISTED
CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S
CNP.PRB
| $6.42M | 0.02% |
180,481
-1,213
| -0.7% | -$40.5K |
|
484
Bio-Rad Laboratories Class A
BIO
$8.71B
| $6.41M | 0.02% |
14,192
+304
| +2% | +$134K |
|
|
PLAN
485
DELISTED
Anaplan, Inc.
PLAN
| $6.38M | 0.02% |
140,778
+58,606
| +71% | +$2.45M |
|
486
Quanterix
QTRX
$164M
| $6.36M | 0.02% |
+232,339
| New | +$5.87M |
|
|
GNMK
487
DELISTED
GenMark Diagnostics, Inc
GNMK
| $6.28M | 0.02% |
+426,628
| New | +$4.33M |
|
488
Essent Group
ESNT
$6.08B
| $6.25M | 0.02% |
172,402
+1,100
| +0.6% | +$33.8K |
|
489
Insmed
INSM
$21.4B
| $6.2M | 0.02% |
225,107
-118,851
| -35% | -$2.82M |
|
490
Tactile Systems Technology
TCMD
$635M
| $6.19M | 0.02% |
149,320
+34,356
| +30% | +$1.61M |
|
491
Fidelity National Information Services
FIS
$23.1B
| $6.13M | 0.02% |
45,717
-177,009
| -79% | -$23.2M |
|
492
Castle Biosciences
CSTL
$855M
| $6.07M | 0.02% |
160,939
+23,870
| +17% | +$816K |
|
|
SYNH
493
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $5.95M | 0.02% |
102,100
-68,014
| -40% | -$3.66M |
|
494
Core Laboratories
CLB
$488M
| $5.92M | 0.02% |
+291,083
| New | +$5.22M |
|
495
Fortive
FTV
$17.9B
| $5.91M | 0.02% |
138,601
+2,852
| +2% | +$111K |
|
496
Krystal Biotech
KRYS
$10.1B
| $5.87M | 0.02% |
141,660
-74,932
| -35% | -$3.6M |
|
497
Trimble
TRMB
$13.2B
| $5.84M | 0.02% |
135,163
+2,880
| +2% | +$108K |
|
|
CTLT
498
DELISTED
CATALENT, INC.
CTLT
| $5.83M | 0.02% |
+79,515
| New | +$5.4M |
|
499
Sixth Street Specialty
TSLX
$1.63B
| $5.78M | 0.02% |
350,425
-21,000
| -6% | -$349K |
|
500
Vale
VALE
$64.1B
| $5.71M | 0.02% |
554,260
+141,523
| +34% | +$1.29M |
|
Similar funds
Lord, Abbett & Co's Q2 2020 Portfolio in Review
As of Q2 2020, Lord, Abbett & Co held 713 positions worth $28.6B, up 27% from $22.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Lord, Abbett & Co withdrew a net $1.19B in Q2 2020, closing 78 positions and reducing 260 holdings. Its most notable exit was Raytheon Company, an estimated $87.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Lord, Abbett & Co opened a new position in Immunomedics Inc worth $117M.
- Lord, Abbett & Co's largest Q2 2020 buy was Immunomedics Inc: 3,306,343 shares worth $117M.
- Lord, Abbett & Co added most to Texas Instruments in Q2 2020, an estimated $99.4M increase.
- Lord, Abbett & Co's biggest Q2 2020 reduction was Shopify, cutting an estimated $122M.
- Lord, Abbett & Co fully exited Raytheon Company in Q2 2020, selling an estimated $87.9M.
- Lord, Abbett & Co's ten largest holdings make up 12% of its $28.6B portfolio in Q2 2020.
- Lord, Abbett & Co opened 83 new positions and closed 78 in Q2 2020.
- Lord, Abbett & Co's portfolio value rose 27% quarter-over-quarter to $28.6B.
Based on Lord, Abbett & Co's 13F filing for Q2 2020, filed 14 Aug 2020.